CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-01 | Cundari Dominic R Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2024-06-01 | Pauls Dietrich John President and CEO | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2024-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-06-01 | Pilnik Richard D. Director | Grant or award · Stock Option (right to buy) | +36,065 | 36,065 | ||
| 2024-06-01 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-06-01 | Lewis Tanya Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-06-01 | Kuntz Richard Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-06-01 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +28,472 | 28,472 | ||
| 2024-01-22 | Lorianne Masuoka K. Chief Medical Officer | Grant or award · Stock option (right to buy) | +285,000 | 285,000 | ||
| 2024-01-02 | Semba Charles Pauling Director | Grant or award | +9,375 | $2.80 | $26K | 39,318 |
| 2024-01-02 | Kuntz Richard Director | Grant or award | +14,285 | $2.80 | $40K | 14,285 |
| 2024-01-02 | Pilnik Richard D. Director | Grant or award | +30,357 | $2.80 | $85K | 278,602 |
| 2024-01-02 | Parsons James T. Director | Grant or award | +21,428 | $2.80 | $60K | 59,937 |
| 2024-01-02 | Giuffre Randall Michael Director | Grant or award | +19,196 | $2.80 | $54K | 364,551 |
| 2023-11-16 | Wambeke David J. Chief Business Officer | Purchase | +20,000 | $2.46 | $49K | 527,114 |
| 2023-06-23 | Von Koch Thomas 10% owner | Purchase | +1,470,588 | $3.40 | $5.0M | 4,326,435 |
| 2023-06-23 | Giuffre Randall Michael Director | Purchase | +65,000 | $3.91 | $254K | 360,355 |
| 2023-06-23 | Giuffre Randall Michael Director | Gift | −15,000 | 345,355 | ||
| 2023-06-23 | Pauls Dietrich John President and CEO | Purchase | +12,787 | $3.91 | $50K | 68,591 |
| 2023-06-23 | Semba Charles Pauling Director | Purchase | +12,787 | $3.91 | $50K | 29,943 |
Page 4 of 10 · 189 trades